Skip to main content
ZYUS Life Sciences Corporation logo

ZYUS Life Sciences Corporation — Investor Relations & Filings

Ticker · ZYUS ISIN · CA9899601095 TSXV Professional, scientific and technical activities
Open in API
Filings indexed 299 across all filing types
Latest filing 2025-08-26 Regulatory Filings
Country CA Canada
Listing TSXV ZYUS

About ZYUS Life Sciences Corporation

https://www.zyus.com/

ZYUS Life Sciences Corporation is a clinical-stage life sciences company dedicated to the development and commercialization of novel, non-opioid pharmaceutical drug candidates. The company focuses on proprietary cannabinoid-based therapeutics, or phyto-therapeutics, targeting the treatment of chronic and neuropathic pain. ZYUS's vision is to redefine the standard of care in pain management by developing evidence-based alternatives to conventional treatments, including opioids and NSAIDs. The core business involves advancing these drug product candidates through clinical trials, exemplified by the ongoing Phase 2a UTOPIA-1 trial evaluating a novel non-opioid pain drug.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2025-08-26 English
Report of exempt distribution (45-106F1).pdf
Regulatory Filings
2025-08-21 English
News release - English.pdf
Regulatory Filings
2025-08-16 English
Report of exempt distribution (45-106F1).pdf
Share Issue/Capital Change Classification · 85% confidence The document is a Canadian securities regulatory form (Form 45-106F1) reporting an exempt distribution of securities (units, warrants, etc.) by an issuer. It provides detailed information on the issuance dates, security types, amounts, jurisdictions, and compensation. This is not an annual, quarterly, or investor presentation, nor an AGM or earnings release. It is a mandatory regulatory filing that announces the issuance of new securities. Under the filing definitions, announcements of new share issues or capital structure changes are classified as ‘Share Issue/Capital Change’ (SHA).
2025-08-06 English
News release - English.pdf
Capital/Financing Update Classification · 92% confidence The document is a corporate press release announcing the closing of the first tranche of a non-brokered private placement of units, detailing the number of units issued, pricing, warrant terms, use of proceeds, and regulatory compliance. This content clearly falls under financing activities and capital structure updates rather than an earnings release, management discussion, or regulatory filing notice. Therefore, it should be classified as a Capital/Financing Update (CAP).
2025-07-30 English
Material change report - English.pdf
Board/Management Information Classification · 95% confidence The document is a Canadian NI 51-102F3 Material Change Report, announcing the appointment of a new Chief Medical Officer (a senior management change). It’s not a full annual or interim financial report, nor an earnings release, but specifically a disclosure of a change in senior management. This aligns with the Board/Management Information category (MANG).
2025-07-15 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.